Stock Events

Direxion Daily S&P Biotech Bear 3X Shares 

$5.56
41
+$0.04+0.72% Wednesday 20:00

Statistics

Day High
5.63
Day Low
5.2
52W High
29.92
52W Low
5.2
Volume
25,446,968
Avg. Volume
15,622,649
Mkt Cap
-
P/E Ratio
-
Dividend Yield
7.76%
Dividend
0.43

Upcoming

24
SEP
Dividend Ex
Estimated
 
1
OCT
Dividend Payment
Estimated
 
23
DEC
Dividend Ex
Estimated
 
31
DEC
Dividend Payment
Estimated
 
19
MAR 25
Dividend Ex
Estimated
 
26
MAR 25
Dividend Payment
Estimated
 
25
JUN 25
Dividend Ex
Estimated
 
2
JUL 25
Dividend Payment
Estimated
 
19
SEP 25
Dividend Ex
Estimated
 
26
SEP 25
Dividend Payment
Estimated
 

Dividends

7.76%Dividend Yield
Oct 24
$0.19
Jul 24
$0.09
Mar 24
$0.07
Dec 23
$0.08
Sep 23
$0.19
10Y Growth
N/A
5Y Growth
14.82%
3Y Growth
N/A
1Y Growth
-27.37%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LABD. It's not an investment recommendation.
Alphabet
73648
GOOGL
Apple
64217
AAPL
Microsoft
59917
MSFT
Amazon
55249
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Direxion Daily S&P Biotech Bull 3X Shares
LABU
Mkt Cap0
Direxion Daily S&P Biotech Bull 3X Shares, the bullish counterpart to LABD, offering 3x leveraged exposure to the same index but for those betting on the index's rise.
ProShares UltraShort Nasdaq Biotechnology -2x Shares
BIS
Mkt Cap0
ProShares UltraShort Nasdaq Biotechnology, offers 2x daily short leverage to the NASDAQ Biotechnology Index, competing directly with LABD's inverse biotech focus.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, provides exposure to the biotech industry, competing with LABD by targeting the same sector without leverage.
iShares Biotechnology
IBB
Mkt Cap0
iShares Biotechnology ETF, tracks the same biotech sector as LABD, offering an alternative for investors looking to invest in biotech without leverage.
SPDR Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF, competes by offering exposure to the biotech sector, similar to LABD but without the leveraged inverse strategy.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF, targets the biotech and healthcare sectors, providing an alternative investment in the same industry as LABD.
ProShares Ultra Nasdaq Biotechnology 2X Shares
BIB
Mkt Cap0
ProShares Ultra Nasdaq Biotechnology, offers 2x daily leverage to the NASDAQ Biotechnology Index, competing with LABD by targeting the same sector with a bullish perspective.
Zenas Biopharma
ZBIO
Mkt Cap3.51M
ProShares UltraPro Short NASDAQ Biotechnology, provides 3x daily inverse leverage to the NASDAQ Biotechnology Index, directly competing with LABD's 3x inverse strategy.
Virtus LifeSci Biotech Products
BBP
Mkt Cap0
Virtus LifeSci Biotech Products ETF, competes by investing in biotech product companies, offering a different angle on the same sector as LABD.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund, competes by providing exposure to biotech firms, similar to LABD's focus but without the leveraged inverse strategy.

About

Miscellaneous
Investment Trusts/Mutual Funds
The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Show more...
CEO
Country
US
ISIN
US25460G7161

Listings

ARCX
US
LABD
MX
MX
LABD.MX